BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aarestrup J, Jess T, Kobylecki CJ, Nordestgaard BG, Allin KH. Cardiovascular Risk Profile Among Patients With Inflammatory Bowel Disease: A Population-based Study of More Than 100 000 Individuals. J Crohns Colitis. 2019;13:319-323. [PMID: 30321330 DOI: 10.1093/ecco-jcc/jjy164] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Wu H, Hu T, Xu M, Hao H, Hill MA, Xu C, Liu Z. Examining endothelial function and carotid artery disease in patients with inflammatory bowel disease: a systematic review protocol. BMJ Open 2022;12:e059785. [PMID: 35697459 DOI: 10.1136/bmjopen-2021-059785] [Reference Citation Analysis]
2 Wu H, Xu M, Hao H, Hill MA, Xu C, Liu Z. Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:3179. [PMID: 35683564 DOI: 10.3390/jcm11113179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sleutjes JAM, Roeters van Lennep JE, van der Woude CJ, de Vries AC. Lipid Changes After Induction Therapy in Patients with Inflammatory Bowel Disease: Effect of Different Drug Classes and Inflammation. Inflamm Bowel Dis 2022:izac100. [PMID: 35590447 DOI: 10.1093/ibd/izac100] [Reference Citation Analysis]
4 Mironova OI, Isaikina MA, Khasieva SA. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Terapevticheskii arkhiv 2022;93:1533-8. [DOI: 10.26442/00403660.2021.12.201225] [Reference Citation Analysis]
5 Zhou L, Yan F, Jiang R, Liu J, Cai L, Wang Y. Administration of Nrf-2-Modified Hair-Follicle MSCs Ameliorates DSS-Induced Ulcerative Colitis in Rats. Oxid Med Cell Longev 2021;2021:9930187. [PMID: 34745427 DOI: 10.1155/2021/9930187] [Reference Citation Analysis]
6 Wu H, Hu T, Hao H, Hill MA, Xu C, Liu Z, Mellbin L. Inflammatory bowel disease and cardiovascular diseases: a concise review. European Heart Journal Open 2022;2:oeab029. [DOI: 10.1093/ehjopen/oeab029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Carrillo-Palau M, Hernández-Camba A, Ramos L, Vela M, Arranz L, Hernández Alvarez-Buylla N, Alonso-Abreu I, Hernández-Pérez A, Hernández-Guerra M, Palazuelos C, Llorca J, González-Gay MÁ, Ferraz-Amaro I. QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease. J Clin Med 2021;10:4102. [PMID: 34575213 DOI: 10.3390/jcm10184102] [Reference Citation Analysis]
8 Sleutjes JAM, Roeters van Lennep JE, Boersma E, Menchen LA, Laudes M, Farkas K, Molnár T, Kennedy NA, Pierik MJ, van der Woude CJ, de Vries AC. Systematic review with meta-analysis: effect of inflammatory bowel disease therapy on lipid levels. Aliment Pharmacol Ther 2021;54:999-1012. [PMID: 34453860 DOI: 10.1111/apt.16580] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Olivera PA, Zuily S, Kotze PG, Regnault V, Al Awadhi S, Bossuyt P, Gearry RB, Ghosh S, Kobayashi T, Lacolley P, Louis E, Magro F, Ng SC, Papa A, Raine T, Teixeira FV, Rubin DT, Danese S, Peyrin-Biroulet L. International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34453143 DOI: 10.1038/s41575-021-00492-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
10 Sleutjes JAM, van Lennep JER, van der Woude CJ, de Vries AC. Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management. Therap Adv Gastroenterol 2021;14:17562848211032126. [PMID: 34377149 DOI: 10.1177/17562848211032126] [Reference Citation Analysis]
11 Hasbey I, Ufuk F, Kaya F, Celik M. Cardiac MRI findings in patients with Crohn's disease. Ir J Med Sci 2021. [PMID: 34279800 DOI: 10.1007/s11845-021-02717-w] [Reference Citation Analysis]
12 Ruskovska T, Massaro M, Carluccio MA, Arola-Arnal A, Muguerza B, Vanden Berghe W, Declerck K, Bravo FI, Calabriso N, Combet E, Gibney ER, Gomes A, Gonthier MP, Kistanova E, Krga I, Mena P, Morand C, Nunes Dos Santos C, de Pascual-Teresa S, Rodriguez-Mateos A, Scoditti E, Suárez M, Milenkovic D. Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic disease. Food Funct 2020;11:5040-64. [PMID: 32537624 DOI: 10.1039/d0fo00701c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
13 Sbeit W, Kadah A, Mahamid M, Mari A, Khoury T. The interplay between gastrointestinal and cardiovascular diseases: a narrative review focusing on the clinical perspective. Eur J Gastroenterol Hepatol 2021;32:132-9. [PMID: 32516176 DOI: 10.1097/MEG.0000000000001779] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kamperidis N, Kamperidis V, Zegkos T, Kostourou I, Nikolaidou O, Arebi N, Karvounis H. Atherosclerosis and Inflammatory Bowel Disease-Shared Pathogenesis and Implications for Treatment. Angiology 2021;72:303-14. [PMID: 33601945 DOI: 10.1177/0003319720974552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Li W, Yu J, Xiao X, Li W, Zang L, Han T, Zhang D, Niu X. The inhibitory effect of (-)-Epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis. Eur J Pharmacol 2021;891:173761. [PMID: 33249078 DOI: 10.1016/j.ejphar.2020.173761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Sinh P, Cross R. Cardiovascular Risk Assessment and Impact of Medications on Cardiovascular Disease in Inflammatory Bowel Disease. Inflamm Bowel Dis 2021;27:1107-15. [PMID: 32978937 DOI: 10.1093/ibd/izaa258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Czubkowski P, Osiecki M, Szymańska E, Kierkuś J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med 2020;20:481-91. [PMID: 32785793 DOI: 10.1007/s10238-020-00639-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Weissman S, Sinh P, Mehta TI, Thaker RK, Derman A, Heiberger C, Qureshi N, Amrutiya V, Atoot A, Dave M, Tabibian JH. Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol 2020; 11(5): 104-113 [PMID: 32832194 DOI: 10.4291/wjgp.v11.i5.104] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
19 Viscido A, Capannolo A, Petroni R, Stefanelli G, Zerboni G, De Martinis M, Necozione S, Penco M, Frieri G, Latella G, Romano S. Association between Corrected QT Interval and C-Reactive Protein in Patients with Inflammatory Bowel Diseases. Medicina (Kaunas) 2020;56:E382. [PMID: 32751480 DOI: 10.3390/medicina56080382] [Reference Citation Analysis]
20 Macaluso FS, Rodríguez-lago I. JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease. CDM 2020;21:247-55. [DOI: 10.2174/1389200221666200310111409] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kirchgesner J, Nyboe Andersen N, Carrat F, Jess T, Beaugerie L; BERENICE study group. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut 2020;69:852-8. [PMID: 31446428 DOI: 10.1136/gutjnl-2019-318932] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 11.5] [Reference Citation Analysis]
22 Xie J, Li L, Deng S, Chen J, Gu Q, Su H, Wen L, Wang S, Lin C, Qi C, Zhang Q, Li J, He X, Li W, Wang L, Zheng L. Slit2/Robo1 Mitigates DSS-induced Ulcerative Colitis by Activating Autophagy in Intestinal Stem Cell. Int J Biol Sci 2020;16:1876-87. [PMID: 32398956 DOI: 10.7150/ijbs.42331] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
23 Zhang Y, Shen B, Zhuge L, Xie Y. Identification of differentially expressed genes between the colon and ileum of patients with inflammatory bowel disease by gene co-expression analysis. J Int Med Res 2020;48:300060519887268. [PMID: 31822145 DOI: 10.1177/0300060519887268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Villumsen M, Jess T, Allin KH. Reply. Clin Gastroenterol Hepatol 2020;18:1003-4. [PMID: 31606454 DOI: 10.1016/j.cgh.2019.10.006] [Reference Citation Analysis]
25 Williams JW, Huang LH, Randolph GJ. Cytokine Circuits in Cardiovascular Disease. Immunity 2019;50:941-54. [PMID: 30995508 DOI: 10.1016/j.immuni.2019.03.007] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 17.0] [Reference Citation Analysis]
26 Bunu DM, Timofte CE, Ciocoiu M, Floria M, Tarniceriu CC, Barboi OB, Tanase DM. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies. Gastroenterol Res Pract 2019;2019:3012509. [PMID: 30733802 DOI: 10.1155/2019/3012509] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 11.7] [Reference Citation Analysis]